Price T Rowe Associates Inc Dexcom Inc Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Dexcom Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,215,069 shares of DXCM stock, worth $245 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,215,069
Previous 3,449,901
6.81%
Holding current value
$245 Million
Previous $391 Million
44.9%
% of portfolio
0.02%
Previous 0.05%
Shares
16 transactions
Others Institutions Holding DXCM
# of Institutions
1,013Shares Held
351MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.62 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.63 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.37 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.27 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.15 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $29.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...